CAPR — Capricor Therapeutics Inc

Ownership history in Pier Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Pier Capital, LLC reported a position in Capricor Therapeutics Inc (CAPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.56% (2025 Q1)
Avg. % of fund
0.56%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 496,554 +128,837 +35.0% 0.56% $3.6M $7.21
2025 Q2 ADDED 367,717 +13,536 +3.8% 0.56% $3.7M $9.93
2025 Q1 INITIATED 354,181 — — 0.56% $3.4M $9.49
% of Fund (quarterly)    CAPR price (monthly, adj. close)

Other funds also holding CAPR

As of 2025 Q4 — sorted by position size

DG Capital Management, LLC 3Y 7Y 5.24% SB Capital Management Inc 4.23% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 2.42% SUPERSTRING CAPITAL MANAGEMENT LP 1.49% Ikarian Capital, LLC 3Y 1.3% MOODY ALDRICH PARTNERS LLC 3Y 7Y 1.12% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.06% Palo Alto Investors LP 3Y 7Y 0.91% Soleus Capital Management, L.P. 3Y 0.69% Persistent Asset Partners Ltd 0.67%
← Back to Pier Capital, LLC Holdings